<DOC>
	<DOCNO>NCT01335984</DOCNO>
	<brief_summary>This multi-centered , randomize , parallel group , interventional &amp; open label clinical trial access efficacy intervention effect smart care system exist treatment group lower blood pressure hypertension patient take anti-hypertension drug .</brief_summary>
	<brief_title>Effects Telemonitoring Telemedicine Service Hypertensive Care</brief_title>
	<detailed_description>1 . Objectives : To evaluate superiority blood pressure lower effect Smart Care Service compare conventional treatment hypertensive patient receive conventional antihypertensive medication 2 . Test control group - Control group : The subject group receive conventional treatment ( hospital visit ) . - Test group Conventional treatment + remote monitor group : The subject group receive health care service use conventional treatment ( hospital visit ) remote monitor . Remote visit + remote monitor group : The subject group receive remote visit remote monitor use videotelephony 3 . Target Subject : Hypertensive patient receive conventional antihypertensive medication</detailed_description>
	<criteria>1 . Male female patient able receive outpatient treatment 20 70 year age . Over SBP 140mmHg without diabetes renal failure 2 . Patients take one kind antihypertensive medication Systolic blood pressure ( SBP ) ≥ 140mmHg patient diabetes mellitus renal disease Systolic blood pressure ( SBP ) ≥ 130mmHg patient without diabetes mellitus renal disease 3 . Patients able understand purpose trial read write 4 . Patients able use Smart Care PC trial 5 . Patients participate voluntarily sign informed consent 1 . Patients severe hypertension ( mean two seat SBP ≥200 mmHg ) screen visit blood pressure measurement . 2 . Patients secondary hypertension . 3 . HbA1c &gt; 11 % . 4 . Patients currently hospitalize planning hospitalize due hypertension . 5 . Patients severe renal disease ( 1.5 time upper limit normal serum creatinine level ) . 6 . Patients severe liver disease include cirrhosis ( AST ALT : 3 time upper limit normal ) . 7 . Patients suffer cardiac infarction severe coronary artery disease within 6 month , clinically significant congestive heart failure heart valve defect . 8 . Patients phthisis , autoimmune disease connective tissue disease . 9 . Patients medication therapy may interfere blood pressure . 10 . Patients known history allergic reaction contraindication angiotensin II antagonists . 11 . Pregnant lactate woman . 12 . Patients known history alcoholism , mental illness , drug dependency . 13 . Patients participate study within 12 week prior screen visit . 14 . Any clinically significant medical condition include neurologic disease , gastrointestinal disease malignant tumor , etc. , may affect test result , medical condition opinion investigator make patient unsuitable participation trial .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>telemonitoring</keyword>
	<keyword>usual care</keyword>
	<keyword>telemedicine</keyword>
	<keyword>telehealth</keyword>
	<keyword>home care</keyword>
	<keyword>Health Care Quality</keyword>
	<keyword>Access</keyword>
	<keyword>Evaluation</keyword>
</DOC>